Nicholas A Saccomano's Net Worth

$11.1 Million

Estimate Recalculated Nov 1, 2024 08:59AM EST

Who is Nicholas A Saccomano

Nicholas A Saccomano has an estimated net worth of $11.1 Million. This is based on reported shares in ARRAY BIOPHARMA INC.

SEC CIK

Nicholas A Saccomano's CIK is 0001609284

Past Insider Trading and Trends

2018 was Nicholas A Saccomano's most active year for acquiring shares with 5 total transactions. Nicholas A Saccomano's most active month to acquire stocks was the month of November. 2019 was Nicholas A Saccomano's most active year for disposing of shares, totalling 15 transactions. Nicholas A Saccomano's most active month to dispose stocks was the month of March. 2019 saw Nicholas A Saccomano paying a total of $1,087,500.00 for 296,250 shares, this is the most they've acquired in one year. In 2019 Nicholas A Saccomano cashed out on 1,407,740 shares for a total of $11,799,661.91, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ARRAY BIOPHARMA INC

CSO
Updated Jul 30, 2019
Form 4
-100.00%
-896.75K
$48.00
Jul 30, 2019
Disposition
Jul 30
Form 4
-4.05%
-6.05K
$24.60
-$148.78K
Apr 03, 2019
157.07K
Options
Apr 01
Form 4
-45.42%
-187.26K
$12.63
-$3.35M
Feb 08, 2019
224.99K
Sale
ScheduledFeb 07
Form 4
-7.97%
-21.43K
$11.44
-$13.55
Feb 04, 2019
247.25K
Options
Jan 31
Form 4
146.57%
155.51K
$15.97
-$87.60K
Dec 18, 2018
261.62K
Options
Dec 14 - Dec 16
Form 4
-7.55%
-5.04K
$18.50
-$93.20K
Jun 29, 2018
61.69K
Options
Jun 27
Form 4
-8.14%
-6.12K
$16.32
-$99.85K
Apr 03, 2018
69.03K
Options
Apr 01
Form 4
263.29%
193.45K
$10.92
-$27.82K
Dec 19, 2017
266.93K
Options
Dec 16
Form 4/A
-14.74%
-6.54K
$8.94
-$58.49K
Apr 06, 2017
37.85K
Tax
Apr 01
Form 4
-7.23%
-4.54K
$8.94
-$40.54K
Apr 04, 2017
58.15K
Options
Apr 01
Form 4
153.13K
Dec 29, 2016
153.13K
Grant
Dec 27
Form 4
503.14%
189.94K
$3.00
-$7.69K
Apr 05, 2016
227.69K
Grant
Apr 01
Form 4
2,319.28%
192.50K
Apr 03, 2015
200.80K
Grant
Apr 01
Form 4
-17.61%
-4.03K
$7.96
$59.06K
Mar 04, 2015
18.87K
Options
Mar 01
Form 4
22.91K
Aug 20, 2014
22.91K
Grant
Aug 18
Form 3
Jun 03, 2014
Showing 16 results

OnKure Therapeutics, Inc.

President and CEO
Updated Oct 08, 2024
Form 3
Oct 08, 2024
Showing 1 results